Analyst Ratings for Madrigal Pharmaceuticals (MDGL)
MDGL Rating Summary
MDGL Price Target Summary
- Highest: $962.00 (Barclays)
- Lowest: $510.00 (Leerink)
- Average: $687.19
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$687.19 (+52.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
Avg. $ Target:
$687.19 (+52.8%)
* Over Last 12-Mos
Rating Score: 8.8 / 10
Percentile Rank: 88%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/24/2026 | Goldman Sachs | Andrea Newkirk | New Coverage | Buy (N/A) |
704.00 (N/A) |
518.83 (449.74) |
-13.32% | Details |
| 9/23/2026 | Citi | Eric Joseph | New Coverage | Buy (N/A) |
725.00 (N/A) |
518.83 (449.74) |
-13.32% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
